Charts
From 02/05/2022 our Markets Data content will no longer be free to read. To continue to get full access, subscribe now and receive 25% off.
Equities

Alkem Laboratories Ltd

Alkem Laboratories Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)5,779.25
  • Today's Change-27.65 / -0.48%
  • Shares traded140.72k
  • 1 Year change+55.36%
  • Beta0.6142
Data delayed at least 15 minutes, as of Oct 31 2024 10:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Key statistics

On Thursday, Alkem Laboratories Ltd (ALKEM:NSI) closed at 5,779.25, -10.26% below its 52-week high of 6,439.90, set on Sep 13, 2024.
52-week range
Today
3,676.05Nov 01 20236,439.90Sep 13 2024
Open5,794.65
High5,854.50
Low5,763.40
Bid--
Offer--
Previous close5,806.90
Average volume186.11k
Shares outstanding119.57m
Free float37.55m
P/E (TTM)33.73
Market cap692.95bn INR
EPS (TTM)171.81
INR
Annual div (ADY)40.00
INR
Annual div yield (ADY)0.69%
Div ex-dateAug 09 2024
Div pay-dateSep 04 2024
Data delayed at least 15 minutes, as of Oct 31 2024 10:02 BST.
More ▼

Events & Activity

  • ALKEM:NSI price moved over +1.04% to 6,004.40
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.